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Modeling

Development of a rapidly computable descriptor of prostate
tissue temperature during transurethral conductive heat therapy
for benign prostate hyperplasia
U. H. PATEL

C. F. BABBS

Biomedical Engineering Center, Purdue University, West Lafayette, Indiana, USA.

Abstract—Benign prostate hyperplasia (BPH) is a condition in older men in which the mass of
tissue in the prostate gland gradually increases over the course of many years, ultimately leading
to urinary outflow obstruction. Current treatment of this condition is to surgically remove the
obstructing tissue. One novel alternative therapy being studied is transurethral
thermocoagulation of excessive prostatic mass. In this approach, a heat emitting catheter is
placed in the prostatic urethra, and the intraprostatic segment of the catheter is heated to
temperatures above 60 oC for one hour. Two dimensional cylindrical coordinate computer
simulations of this treatment modality were run to model resultant temperature distributions
within the prostate gland and surrounding tissues. The simulations revealed that resultant tissue
temperature changes were related directly to the power delivered to the catheter and inversely to
the rate of blood perfusion. Further analysis of the temperature profiles produced a rapidly
computable predictor of tissue temperature in the radial dimension. Using the predictor, a ‘kill
radius’ around the prostatic urethra can be easily computed online, during treatment, from
clinically available data: the catheter power and catheter temperature. The computed kill radius
may serve as a useful predictor of the extent of thermal devitalization of unwanted obstructing
tissue and the long term success of the treatment in relieving urinary outflow obstruction without
surgery.
Key words—Benign prostatic hyperplasia, BPH, Conductive heating, Prostate gland,
Thermocoagulation
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1 Introduction
Benign prostatic hyperplasia (BPH) is a condition characterized by non-malignant proliferation
of tissue within the capsule of the prostate gland, ultimately leading to obstruction of urinary
flow through the prostatic urethra. BPH is estimated to affect about 50 percent of men over the
age of 60 years; in men over 80 years of age, 80 percent are affected (HULBERT, 1989).
The traditional treatment for urinary obstruction due to BPH is the surgical removal of
hyperplastic prostatic tissue, usually by endoscopic transurethral reaction of the prostate (TURP).
In 1983, approximately 357,000 men in the USA underwent prostatic resection, either by
transurethral or by abdominal approaches (ERCOLE, 1989). In a multi-center study, MEBUST
et al. (1989) found that, although the surgical mortality due to transurethral resection was low (02 per cent), the morbidity of the procedure (failure to void, bleeding requiring transfusions, clot
retention, and genitourinary infections) was 18 per cent. For patients older than 80 years, the
morbidity was 22.6 per cent. When the duration of procedure was greater than 90 min, intraoperative bleeding requiring a blood transfusion occurred in 7-3 percent of cases. The cost of
TURP for each patient totals about $10,000, owing to the need for hospitalization, surgeon's and
anesthetist's fees and operating room time (CASTANEDA et al., 1987).
A variety of alternatives to TURP are being investigated. Medical treatment of BPH with
endocrine and alpha-adrenergic blocker therapy has been somewhat successful; however, the
effects are reported to be temporary (ERCOLE, 1989). For patients in whom surgery is not
indicated, long term intra-urethral prostheses have been tried to treat urinary flow obstruction
(VINCENTE et al., 1989), but these devices promoted an undesirable incidence of urinary tract
infection. Another procedure being investigated is prostatic urethroplasty with a balloon catheter
(CASTANEDA et al., 1987). Reported results from this procedure have been mixed
(GONZALEZ et al., 1989; HERRERA et al., 1989; MACHAN et al., 1989). Complications
include initial hematuria, which usually clears in 24 hours, severe delayed hemorrhage, and acute
urinary retention (CASTANEDA, 1989). Microwave hyperthermia is also under investigation as
an alternative to TURP. As with balloon dilatation, the results have been mixed (SAPOZTNK et
al., 1990; STROHMAIER et al., 1990). Short term complications of microwave hyperthermia
include hematuria, bladder spasm, and dysuria.
This paper describes theoretical studies of a potential new modality for the minimally invasive
treatment of BPH; transurethral thermocoagulation of the prostate. In contrast to hyperthermia
therapy at 42-46 oC generated by transurethral microwave techniques (SAPOZINK et al., 1990),
thermocoagulation involves the deliberate generation of high temperatures (> 60 oC for 1 hr)
sufficient to cause coagulative necrosis of treated periurethral tissue. The goal is to coagulate an
annular sleeve of periurethral prostatic tissue, which will subsequently be resorbed with minimal
bleeding, followed by regeneration of the urethral epithelium and relief of urinary outflow
obstruction. Technology currently under development for transurethral thermocoagulation
includes a 7-10 Fr (2.2-3.2 mm diameter) catheter containing a wire wound, electrically heated
resistor near the catheter tip (Fig. 1). Catheters may be selected with the heating element ranging
from 3 to 4 cm in length to match the ultrasonically measured prostatic dimensions in individual
patients. A high thermal conductivity elastomer is used to couple the heating element to the
polyethylene covering. To monitor and control the temperature of the heating element, a high
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precision thermistor is located at the center of the heating element. In operation, the catheter is
placed in the prostatic urethra with the aid of transrectal ultrasonography to verify the catheter
position. Direct current is then applied to the catheter and the power is adjusted via computer
control such that the internal catheter temperature is held constant. Heat is delivered to the tissue
by thermal conduction only, as in other recently developed conductive heating techniques
(DEFORD et al., 1991).
Preliminary trials (unpublished study) using this procedure in the canine model have been
encouraging. The internal catheter temperatures, ranging from 59 to 87 oC were generated for 2060 min. Histopathologic findings immediately following heat treatment revealed coagulative
necrosis extending 1 to 3 cm radially from the catheter edge into periurethral stroma and
glandular elements. Treated prostate glands studied 2, 4, or 8 weeks after thermocoagulation by
retrograde urethrography and light microscopy exhibited a consistent pattern of edema and noninfective inflammation with minimal luminal narrowing at 2 weeks; followed by resolution of
the inflammatory response, re-epithelialization, widening of the prostatic urethra, and atrophy of
the periurethral prostatic glands, with maintenance of the normal architecture of periurethral
connective tissue.
To further refine the technique for clinical use, accurate control of catheter placement and heat
delivery are necessary, so as to not damage normal tissues, such as the urinary sphincter. This
paper describes the use of a computer model to predict temperature distributions created by
conductive thermocoagulation of the prostate and to predict the 'kill radius' within which clearly
cytotoxic temperatures are achieved. A two dimensional cylindrical coordinate model, very
similar to one previously described (PATEL et al., 1991), was used, so that temperature
gradients could be evaluated in both radial and longitudinal dimensions. Evaluation of the
simulated temperature distribution led to the development of a rapidly computable predictor of
periprostatic temperature distributions.
2 Computational methods
2.1 Theory
The computational formulae used in this study were based on the bioheat transfer equation first
described by PENNES (1948) for a small control volume of tissue:

q met  P  K 2 T  c b b Tb  T   c

T
,
t

(1)

where q met is the specific rate of metabolic heat production, P is the power density delivered to
tissue, K is the tissue thermal conductivity, T is the temperature of tissue, cb is the specific heat
of blood, b is the specific flow rate of blood in capillaries, T b is the temperature of blood,  is
the mass density of tissue, c is the specific heat of tissue, and t is time. The control volume is
small enough that all thermal properties within it are uniform. For an interstitial, conductive
heating modality at steady state, metabolic heat production is small compared with other terms
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(DEFORD, 1989), power is not directly delivered to the tissue, and T / t  0 . Thus, equation
(1) simplifies to

K 2 T  c b b Tb  T   0 .

(2)

Fig. 1 Sketch of tip of conductive heating catheter used for transurethral heating of canine
prostate.
2.2 Modeled volume
The prostate and surrounding tissue were modeled in a cylindrical space, assuming radial
symmetry. Fig. 2 shows a sketch of the model space in cross section. The urethra was modeled as
a potential space occupied by the heat emitting catheter along the central axis. The prostate
region was modeled as the middle elliptical portion of the cylinder. The bladder was modeled as
the top of the cylinder containing fluid at 37 oC. This section tapered down to the urethra. Just
below the prostate, the external, voluntary sphincter was modeled as ring of tissue 1 cm thick
4

with a radius of 2 cm. The remaining volume of the cylinder was modeled as surrounding
connective tissue. The outer edge of the cylinder, x = 3 cm, was clamped to arterial blood
temperature, 37 oC. The bottom of the cylinder was also clamped to arterial blood temperature.
The control volumes in this model were similar to the control volumes described by PATEL et
al. (1991) for computer simulation of hyperthermia therapy in brain tumors. Except for the
central axis, each control volume was a ring of tissue. Heat conduction occurred radially between
control volumes of the same height and longitudinally between control volumes of the same
radius. In this study, each ring had a height dz of 0.04 cm and a width dr of 0.01 cm. Thus, the
entire model space contained 60000 control volumes. Even though this was a two dimensional
model, incorporating radial symmetry for simplicity, the large number and small sizes of the
control volumes were necessary to obtain valid numerical results in the presence of the steep
thermal gradients, dT/dr, associated with conductive heating.
2.3 Computational formulae and simulations
The computational formulae and the methods were identical to those previously derived (PATEL
et al., 1991). The following shows the computational formula used to obtain an iterative solution
to the steady-state bioheat transfer equation for the temperature rise above arterial blood
temperature (C) for the center control volume shown in Fig. 3, which represents a typical ring of
tissue:

(3)
x is the temperature rise above arterial blood temperature for control volume x, Kxy is the
interface thermal conductivity between control volumes x and y (DeFORD et al., 1990), r is
radial distance to the center control volume, cb is the specific heat of blood and b is the blood
perfusion in the tissue control volume. The subscripts C, I, O, U and L are as defined in Fig. 3.
For control volumes containing the heating element, a power deposition term was added to the
numerator and the perfusion term cb b in the denominator was zero. For other areas of the model
space, in which there would be no blood flow (i.e. the catheter components, bladder fluid), the
perfusion term was also zero.
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Fig. 2 Modeled cylindrical volume shown in cross-section. The cylinder has a height of 5 cm and
a radius of 3 cm.
Values for the specific heat of blood (3642.6 J/(kg o C) and for tissue thermal conductivity (0.564
W/(m oC)) were taken from the literature (ALBRITTON, 1952; COOPER and TREZEK, 1971).
The thermal conductivities of the catheter components were obtained from the literature
(INCROPERA and DEWITT, 1981), or measured experimentally, as described previously
(PATEL et al., 1991).
A modified Gauss-Seidel method was used to solve the derived bioheat transfer equations for
each control volume iteratively, beginning with an initial condition of  = 0 everywhere. The
simulations were run on the Ardent Titan-P3 computer (Ardent Computer Corp.) which was
running at 60 MIPS. Each simulation required approximately 1-3 hours to complete.
The output from a simulation was a file containing the steady-state temperature rise for each
control volume for given conditions of catheter power and tissue perfusion. Contour plots were
generated from these data and the thermal profiles were evaluated. Temperature profiles from a
total of 40 simulations were analyzed. Catheter power was varied from 0.5 to 1.0 W/cm and
prostate blood perfusion was varied from 0.05 to 0.7ml/min/g. In all simulations, perfusion in the
sphincter was 0.3 ml/min/g and all other surrounding tissue perfusion was 0.1 ml/min/g. Thus, a
large family of simulations was performed, the analysis of which revealed helpful regularities in
the thermal responses to this geometrically simple heat treatment modality. In turn, it was
possible to derive a much simpler predictor of tissue temperature for use in clinical work than the
complete bioheat equation.
6

Fig. 3 Diagram showing heat conduction between interior control volumes center(C), inner (I),
outer (O), upper (U), and lower (L). Heat conduction occurs radially between control volumes, I,
C and O, and occurs longitudinally between control volumes U, C, and L. Each control volume
has width dr and height dz.
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Fig. 4 Contour plot showing the thermal profile produced from a simulation with a catheter
power of 0.7 W/cm and a prostate blood perfusion of 0.2 ml/min/g. Perfusion in the sphincter
region was 0.3 ml/min/g. All other tissue was modeled with a perfusion of 0.1 ml/min/g. Tissue
thermal conductivity was 0.564 W/(m o C), heating element thermal conductivity was 12.0 W/(m
o
C), and catheter sheath thermal conductivity was 0.4 W/(m o C). Simulations had a radial
resolution of 0.01 cm and longitudinal resolution of 0.04 cm. Each contour represents a 2 oC
change in temperature. Numbers on contours represent the temperature above arterial blood
temperature.
3 Results and predictor development
3.1 Simulation results
Fig. 4 shows a contour plot of steady-state temperature elevations obtained in a typical
simulation. Superimposed on the plot is the outline of the various features in the modeled
volume. The decay of temperature with radial distance, x, from the catheter edge was similar for
most central levels, z, along the heating element. Steep longitudinal temperature gradients
developed only at the ends of the heating element. Fig. 5 shows a plot of radial temperature
profiles in a plane containing the midpoint of the heating element (z = 2.5 cm in Fig. 4) from five
simulations of different catheter power (0.5-1.0 W/cm) and a constant blood perfusion of 0.2
ml/min/g. The radial distance x in this plot is zero at the center of the catheter.
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The temperature profiles obtained were dependent on catheter power. To normalize the results,
the ratio of temperature rise above arterial blood temperature to catheter power in W/cm was
plotted against radial distance (Fig. 6a), and the curves collapsed to a single curve. Fig. 6b shows
this normalization for all perfusion levels simulated. Each curve in Fig. 6b represents five
different power levels and one perfusion level. The relationship shown in Fig. 6b was then used
to develop a predictor of radial tissue temperature that would require far less computation time
than the solution of the entire bioheat equation for 60000 control volumes.

Fig. 5 Radial temperature profiles from five computer simulations with catheter powers of 0.5,
0.6, 0.7, 0.8 and 1.0 W/cm and prostate blood perfusion of 0.2 ml/min/g. The topmost profile is
from a simulation with a catheter power of 1.0 W/cm. Other details are similar to Fig. 4.
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Fig 6. (a) Plot of temperature rise above arterial temperature divided by catheter power P c
against radial distance from the catheter center. Data are shown from the five simulations
described in Fig. 5. (b) The same plot as (a), but data are shown for all perfusion levels
simulated: 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6 and 0.7 ml/min/ g. The topmost curve represents
simulations with a prostate blood perfusion of 0.05 ml/min/g. The lowest curve represents
simulations with a prostate blood perfusion of 0.7 ml/min/g.
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3.2 Predictor development
The curves shown in Fig. 6b were offset from each other due to different levels of perfusion.
Thus, an equation governing the behavior of the curves would have the following form:

T  Ta
 f (, r )
Pc

(4)

Pc is catheter power in W/cm, T  Ta is the tissue temperature rise above arterial blood
temperature in oC, r is the distance away from the catheter edge (xrc) in cm,  is the prostate
blood perfusion in ml/min/g, and f(, r) is a function dependent on perfusion and distance in
o
C/(W-cm). As the curves in Fig. 6b were quasi-exponential in nature, f(, r) was assumed to be
an exponential function. Thus
f (, r )  e g ( , r )

(5)

or

 T  Ta
g(, r )  ln
 Pc


 .


(6)

Therefore, to find g(, r) , lnT  Ta  / Pc  was plotted against distance r for all simulated
perfusion levels (Fig. 7). For r > 0.5 cm, a nearly linear family of curves was obtained, and for
r < 0.5 cm, the curves appeared to be second-order. Thus, to approximate f(, r), the radial
dimension was divided into two regions; near field (r < 0.5 cm) and far field (r > 0.5 cm). For the
near field, f(, r) was of the form ar2 + br + c, where the coefficients a, b, and c were dependent
on perfusion. Using second-order regression analysis, the coefficients a, b, and c were found for
each perfusion level that was simulated. Table 1 summarizes the results showing the values of
the coefficients. Next the coefficients a, b and c were plotted against perfusion and an additional
regression analysis was performed to obtain quadratic equations to describe the near field
coefficients in terms of perfusion .
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Fig. 7 Plot of ln((T  Ta)/Pc) against distance, r (radial distance away from catheter edge). The
near field region shows curves that are second-order in nature, and the far field shows curves
that are linear in nature. The topmost curve represents simulations with a prostate blood
perfusion of 0.05 ml/min/g. The lowest curve represents simulations with a prostate blood
perfusion of 0.7 ml/min/g.
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Table 1 Coefficient values for near and far field estimators; r2 denotes the coefficient of
determination for the least-squares fitted curve or line.

Table 2 Coefficient estimation equations in terms of perfusion; r2 is the coefficient of
determination for the least-squares fitted curves.

For the far field, f(, r) was of the form, mr + b, where the coefficients m and b were
dependent on perfusion. Using linear regression analysis, the coefficients m and b were
obtained (Table 1). Then the coefficients m and b were plotted against perfusion and an
additional regression analysis was performed to obtain quadratic equations to describe the far
field coefficient values in terms of perfusion.
Table 2 summarizes the second-order fits for the coefficient values in terms of perfusion.
Substituting the functions f(, r) and g(, r) in Equation 5 for the near field and far field,
respectively, the estimators of Equations 7 and 8 were obtained:

(7)
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(8)
Equation (7) is a near field estimator, and Equation (8) is the far field estimator. These estimators
could be used to find tissue temperature rise at any distance in the radial direction from the
catheter edge within the heating space.
It is important to note that these estimators do not give valid answers for perfusion levels greater
than 1.0 ml/min/g. If perfusions are greater than 1.0 ml/min/g, predicted temperatures are
overestimated. For prostatic blood perfusion levels modeled within the physiological range, 0.15
0.79 ml/min/g (ANDERSON et al., 1967; HAEENER and LIAVAG, 1969), temperature
estimates are accurate. Figs. 8a and 8b present three dimensional plots showing the behavior of
the near and far field estimators as a function of prostatic blood perfusions less than 1.0 ml/min/g
and of radial distances less than 2.5 cm.
The temperature estimators of Equations 7 and 8 are not clinically useful unless perfusion can
also be estimated. DEFORD et al. (1992) showed that, in conductive heating, tissue perfusion
could be estimated if catheter power and catheter temperature rise were known. Fig. 9 shows a
plot of perfusion against the ratio of catheter power to catheter temperature rise above arterial
blood temperature ( defined as  = Pc/[Tc  Ta] ) obtained from the simulations run in this study.
Each triangle represents five overlapping data points at different power levels. Second-order
regression analysis yielded the following equation that predicts perfusion in terms of

(9)
Positive values for  are obtained only when  is greater than 0.0115 W/(cm o C). In unpublished
experimental studies,  has been well above this value. Thus, by calculating perfusion with
Equation 9 in terms of clinical variables that can be readily measured online (catheter power and
catheter temperature), Equations 7 and 8 can then be used to predict prostatic tissue temperature
at any distance radially away from the catheter edge.
Conversely, it is possible to predict the radial distance from the catheter within which
thermocoagulation is expected to occur. From the work of JAIN and DUDAR (1983), we can
expect coagulation necrosis to occur in tissue raised to 47 oC or more for a minimum of 50 min.
In unpublished animal studies, the 47 oC contour appears to circumscribe the zone of grossly and
histologically observable necrosis of prostatic tissue after transurethral thermocoagulation in the
dog model. Solving Equation 8 for r at 47 oC we obtain

(10)
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for r47 in the far field. Similar analysis can be performed to obtain r47 for the near field. If the
calculated value for r47 is less than 0.5 cm, then r47 should be recalculated using the near field
estimator equation. Thus, the extent of thermocoagulation can be predicted by online
measurements of catheter power and temperature, based on the prior computer solutions of the
bioheat transfer equation presented here. If the predicted kill radius is insufficient, then the
power can be increased during therapy to achieve a target therapeutic coagulation radius.
Conversely, if the computed kill radius is too large, the power can be decreased.
3.3. Predictor verification
To validate the accuracy of the predictor, tissue temperatures calculated by the predictor were
compared with those obtained from computer simulations. This comparison was performed for
two cases: the first, in which catheter power was high and perfusion was low, and the second, in
which catheter power was low and perfusion was high. In the first case the computer simulation
produced a large thermal gradient, and in the second case the computer simulation produced a
small thermal gradient. Fig. 10 shows plots of radial thermal profiles produced from computer
simulations (solid lines) and the radial thermal profiles calculated using the tissue temperature
estimators from Equations 7-9 (broken lines). The upper curves represent profiles using a
catheter power of 1.0 W/cm and a tissue perfusion of 0.05 ml/min/g, and the lower curves
represent profiles using a catheter power of 0.5 W/cm and a tissue perfusion of 0.7 ml/min/g. In
the first case the r47 was 1.02 cm simulated against 1.01 cm predicted; in the second case the r47
was 0.24 cm simulated against 0.24 cm predicted.
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Fig. 8 (a) Three dimensional plot showing behavior of the near field estimator, Equation 7. The
plot shows the calculated value of (T  Ta)/Pc in o C/(W cm) for 0  r  0.5 and 0    1.0
ml/min/g. (b) Three dimensional plot showing the behavior of the far field estimator, Equation 8.
The plot shows the calculated value of (T  Ta)/Pc in oC/(W cm) for 0.5  r  2.5 cm and 0   
1.0 ml/min/g. The plot indicates that estimator is a smooth continuous function even for values of
r greater than 1.5 cm.
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Fig. 9 Plot of tissue perfusion against catheter power divided by catheter temperature rise. Each
triangle represents five power levels. The curve drawn through the data was generated using the
perfusion estimation equation (Equation 9).

Fig. 10 Temperature profiles generated from a computer simulation (solid line) and temperature
predictor (broken line). For the upper curves, starting and 110 oC catheter power was 1.0 W/cm
and perfusion was 0.05 ml/min/g. For the lower curves, catheter power was 0.5 W/cm and
perfusion was 0.7 ml/min/g.
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4 Discussion
This paper presents the development of a rapidly computable, online tissue estimator for
prostatic tissue during transurethral prostatic thermocoagulation. The model used to develop the
predictor assumed that the geometry of the prostate was symmetrical around the urethra, the
thermal properties were uniform, and tissue perfusion was homogeneous within the prostate.
Provided that the thermal conductivities of the prostate and surrounding tissue are of the same
order of magnitude, the assumption of a cylindrical prostate as opposed to a lobular prostate
should have no effect on predictor accuracy.
The accuracy of prediction is also dependent on the accuracy of the perfusion estimate.
Sensitivity analysis showed that, if perfusion is estimated to within 25 per cent of the actual
value, r47 is within 0.7 mm of the actual value as calculated by Equation 10. DEFORD et al.
(1992) showed that perfusion inhomogeneities should not be a factor in temperature predictor
accuracy as long as variations are less than 25 per cent. Finally, this model also assumes that the
catheter is placed completely within the prostatic urethra. If the catheter was misplaced within
the bladder and the bladder contained urine, the power required to heat the catheter would
increase due to convective heat losses in the bladder. Such a situation would cause the predicted
temperatures to be underestimated. Thus, accurate placement of the catheter is necessary for the
predictor to estimate temperatures properly.
This predictor has the ability to estimate mid-plane tissue temperature at any radial distance from
the catheter. If desired, a similar technique to that used in this study could be supplied to develop
a predictor for temperatures in the longitudinal direction. Tissue temperatures could be predicted
online in major regions of the prostate and important periprostatic tissues. Knowledge of the
expected thermal profiles could then be used to adjust catheter power so as to achieve a desired
therapeutic effect. Thus, conductive heat could be applied effectively to the prostate to create a
desired radius of thermocoagulation (r47) sufficient to relieve obstructive symptoms, after
resorption of the coagulated tissues. The most suitable r 47 value could be readily learned from
clinical experience. Then subsequent patients could be treated with sufficient power, adjusted
moment by moment during treatment, to produce the prescribed r47. In this way, formulae
derived would allow physicians to write in advance a geometric prescription for
thermocoagulation of the prostate.
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